Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk Meningioma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk Meningioma	Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Nerve Tissue, central nervous system cancer, meningioma, neoplasm, nervous system disorder, tumor of meninges, vascular cancer	Active, not recruiting	Phase 2	2026-09-29		NCT03971461

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
NYU Langone Health	359

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cleveland Clinic	Cleveland	United States	558
NYU Langone Health	New York	United States	403

Clinical trials